A detailed history of Advisor Group Holdings, Inc. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 14,336 shares of ORGO stock, worth $43,151. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,336
Previous 14,836 3.37%
Holding current value
$43,151
Previous $41,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$2.42 - $3.24 $1,210 - $1,620
-500 Reduced 3.37%
14,336 $41,000
Q2 2024

Aug 13, 2024

SELL
$2.28 - $3.03 $483 - $642
-212 Reduced 1.41%
14,836 $41,000
Q1 2024

May 10, 2024

BUY
$2.61 - $4.49 $3,356 - $5,774
1,286 Added 9.34%
15,048 $42,000
Q4 2023

Feb 12, 2024

BUY
$1.97 - $4.21 $1,183 - $2,530
601 Added 4.57%
13,762 $56,000
Q3 2023

Nov 13, 2023

BUY
$2.34 - $4.43 $6,376 - $12,071
2,725 Added 26.11%
13,161 $41,000
Q2 2023

Aug 10, 2023

BUY
$1.9 - $4.3 $380 - $860
200 Added 1.95%
10,436 $34,000
Q4 2022

Feb 10, 2023

SELL
$2.48 - $3.43 $1,984 - $2,744
-800 Reduced 7.25%
10,236 $27,000
Q3 2022

Nov 14, 2022

BUY
$3.14 - $6.43 $20,554 - $42,090
6,546 Added 145.79%
11,036 $36,000
Q2 2022

Aug 10, 2022

SELL
$4.74 - $8.15 $3,062 - $5,264
-646 Reduced 12.58%
4,490 $22,000
Q1 2022

May 04, 2022

BUY
$6.47 - $9.57 $1,449 - $2,143
224 Added 4.56%
5,136 $39,000
Q3 2021

Nov 05, 2021

BUY
$13.71 - $17.18 $3,866 - $4,844
282 Added 6.09%
4,912 $70,000
Q2 2021

Aug 02, 2021

BUY
$14.92 - $23.23 $13,786 - $21,464
924 Added 24.93%
4,630 $78,000
Q1 2021

May 13, 2021

SELL
$7.33 - $21.06 $733 - $2,106
-100 Reduced 2.63%
3,706 $67,000
Q4 2020

Feb 10, 2021

BUY
$3.63 - $7.53 $363 - $753
100 Added 2.7%
3,806 $29,000
Q3 2020

Nov 12, 2020

SELL
$3.29 - $4.58 $2,595 - $3,613
-789 Reduced 17.55%
3,706 $14,000
Q2 2020

Aug 14, 2020

BUY
$2.86 - $4.61 $2,256 - $3,637
789 Added 21.29%
4,495 $17,000
Q1 2020

May 18, 2020

BUY
$2.92 - $5.31 $10,821 - $19,678
3,706 New
3,706 $12,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $394M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.